Advanced Pancreatic Cancer
Also known as: Advanced Pancreatic cancer
| Drug | Drug Name | Drug Description |
|---|---|---|
| DB00515 | Cisplatin | Cisplatin, cisplatinum or cis-diamminedichloroplatinum(II) (CDDP) is a platinum-based chemotherapy drug used to treat various types of cancers, including sarcomas, some carcinomas (e.g. small cell lung cancer, and ovarian cancer), lymphomas and germ cell tumors. It was the first member of its class, which now also includes carboplatin and oxaliplatin. |
| DB00526 | Oxaliplatin | Oxaliplatin is a platinum-based chemotherapy drug in the same family as cisplatin and carboplatin. It is typically administered in combination with fluorouracil and leucovorin in a combination known as Folfox for the treatment of colorectal cancer. Compared to cisplatin the two amine groups are replaced by cyclohexyldiamine for improved antitumour activity. The chlorine ligands are replaced by the oxalato bidentate derived from oxalic acid in order to improve water solubility. Oxaliplatin is marketed by Sanofi-Aventis under the trademark Eloxatin®. |
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB00530 | Erlotinib | 1 | Completed | 1 |
| DB00441 | Gemcitabine | 1 | Active Not Recruiting | 1 |
| DB00441 | Gemcitabine | 1 | Completed | 3 |
| DB00619 | Imatinib | 1 | Completed | 1 |
| DB00526 | Oxaliplatin | 1 | Completed | 1 |
| DB01229 | Paclitaxel | 1 | Active Not Recruiting | 1 |
| DB06592 | Pegargiminase | 1 | Active Not Recruiting | 1 |
| DB00544 | Fluorouracil | 2 | Recruiting | 1 |
| DB00441 | Gemcitabine | 2 | Recruiting | 1 |
| DB00441 | Gemcitabine | 2 | Unknown Status | 1 |
| DB00762 | Irinotecan | 2 | Recruiting | 1 |
| DB00650 | Leucovorin | 2 | Recruiting | 1 |
| DB09035 | Nivolumab | 2 | Recruiting | 1 |
| DB00526 | Oxaliplatin | 2 | Recruiting | 1 |
| DB01229 | Paclitaxel | 2 | Active Not Recruiting | 1 |
| DB01229 | Paclitaxel | 2 | Recruiting | 1 |
| DB01229 | Paclitaxel | 2 | Unknown Status | 1 |
| DB00910 | Paricalcitol | 2 | Recruiting | 1 |
| DB09037 | Pembrolizumab | 2 | Recruiting | 1 |
| DB09256 | Tegafur | 2 | Active Not Recruiting | 1 |
| DB09256 | Tegafur | 2 | Not Yet Recruiting | 1 |
| DB09256 | Tegafur | 2 | Recruiting | 1 |